Crystal Oaks in Festus, MO

Crystal Oaks is a medicare and medicaid certified nursing home in Festus, Missouri. It is located in Jefferson county at 1500 Calvary Church Road, Po Box 680, Festus, Missouri 63028. You can reach out to the office of Crystal Oaks via phone at (636) 933-1818. This skilled nursing facility has 131 federally certified beds with average occupancy rate of 72.06%. Its legal business name is Crystal Oaks Long Term Care and has the following ownership type - Non Profit - Corporation.

Crystal Oaks (Medicare CCN 265369) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1989 (35 years certified) and the last quality survey was conducted in February, 2020.

Contact Information

Crystal Oaks
1500 Calvary Church Road, Po Box 680, Festus, Missouri 63028
(636) 933-1818


Nursing Home Profile

NameCrystal Oaks
Location1500 Calvary Church Road, Po Box 680, Festus, Missouri
Certified ByMedicare and Medicaid
No. of Certified Beds131
Occupancy Rate72.06%
Medicare ID (CCN)265369
Legal Business NameCrystal Oaks Long Term Care
Ownership TypeNon Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Crystal Oaks from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1467592618
Organization NameCRYSTAL OAKS LONG TERM CARE
Doing Business AsCRYSTAL OAKS
Address1500 Calvary Church Rd, Festus, MO 63028
Phone Number636-933-1818

News Archive

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

New advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are proving far superior to standard radiation procedures used today in safeguarding the healthy tissues surrounding cancerous tumors, and thus improving patient care.

Beckman Coulter announces PMA from FDA for Prostate Health Index

Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies.

Roche to commence clinical study of TB-403 in patients with colorectal and ovarian cancer

BioInvent International AB and ThromboGenics NV announce today that their partner Roche will begin an imaging study with the novel anti-cancer antibody TB-403 (RG7334) in patients with metastatic, treatment-refractory, colorectal and ovarian cancer.

Cord Blood America announces retirement of $1.6 million in debt since July 2009

Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it has retired $1.6 million in debt since July 2009. The Company previously announced it retired $5 million in debt in the first half of 2009.

Scientists back the use of maize as an efficient 'factory' for protein-based pharmaceutical products

Scientists from the Universidad de Lleida (University of Lleida) have published a study confirming that maize seeds are an effective and sure platform within molecular agriculture to alleviate diseases. Over the next few years AIDS could be one of the first diseases to benefit from these results, although regulations for this technology are being developed at the same time as research is being undertaken.

Read more Medical News

› Verified 7 days ago


NPI Number1841909694
Organization NameCRYSTAL OAKS NURSING AND REHAB LLC
Address1500 Calvary Church Road, Festus, MO 63028
Phone Number636-933-1818

News Archive

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

New advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are proving far superior to standard radiation procedures used today in safeguarding the healthy tissues surrounding cancerous tumors, and thus improving patient care.

Beckman Coulter announces PMA from FDA for Prostate Health Index

Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies.

Roche to commence clinical study of TB-403 in patients with colorectal and ovarian cancer

BioInvent International AB and ThromboGenics NV announce today that their partner Roche will begin an imaging study with the novel anti-cancer antibody TB-403 (RG7334) in patients with metastatic, treatment-refractory, colorectal and ovarian cancer.

Cord Blood America announces retirement of $1.6 million in debt since July 2009

Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it has retired $1.6 million in debt since July 2009. The Company previously announced it retired $5 million in debt in the first half of 2009.

Scientists back the use of maize as an efficient 'factory' for protein-based pharmaceutical products

Scientists from the Universidad de Lleida (University of Lleida) have published a study confirming that maize seeds are an effective and sure platform within molecular agriculture to alleviate diseases. Over the next few years AIDS could be one of the first diseases to benefit from these results, although regulations for this technology are being developed at the same time as research is being undertaken.

Read more Medical News

› Verified 7 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Crystal Oaks are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Crystal Oaks give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

New advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are proving far superior to standard radiation procedures used today in safeguarding the healthy tissues surrounding cancerous tumors, and thus improving patient care.

Beckman Coulter announces PMA from FDA for Prostate Health Index

Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies.

Roche to commence clinical study of TB-403 in patients with colorectal and ovarian cancer

BioInvent International AB and ThromboGenics NV announce today that their partner Roche will begin an imaging study with the novel anti-cancer antibody TB-403 (RG7334) in patients with metastatic, treatment-refractory, colorectal and ovarian cancer.

Cord Blood America announces retirement of $1.6 million in debt since July 2009

Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it has retired $1.6 million in debt since July 2009. The Company previously announced it retired $5 million in debt in the first half of 2009.

Scientists back the use of maize as an efficient 'factory' for protein-based pharmaceutical products

Scientists from the Universidad de Lleida (University of Lleida) have published a study confirming that maize seeds are an effective and sure platform within molecular agriculture to alleviate diseases. Over the next few years AIDS could be one of the first diseases to benefit from these results, although regulations for this technology are being developed at the same time as research is being undertaken.

Read more Medical News

› Verified 7 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines0
Total Amount of Fines in Dollars$0
Number of Payment Denials0
Total Number of Penalties0

Patients' Stay Experience:

The resident survey data of Crystal Oaks is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased8.2714.46
Percentage of long-stay residents who lose too much weight4.025.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder24.8248.41
Percentage of long-stay residents with a catheter inserted and left in their bladder2.261.79
Percentage of long-stay residents with a urinary tract infection2.892.65
Percentage of long-stay residents who have depressive symptoms0.295.05
Percentage of long-stay residents who were physically restrained00.23
Percentage of long-stay residents experiencing one or more falls with major injury3.943.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine10093.87
Percentage of long-stay residents who received an antipsychotic medication14.3714.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine10083.88
Percentage of short-stay residents who newly received an antipsychotic medication3.941.79
Percentage of long-stay residents whose ability to move independently worsened9.0117.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication32.7519.7
Percentage of high risk long-stay residents with pressure ulcers3.897.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine10095.98
Percentage of short-stay residents who made improvements in function72.6367.99
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine96.4882.93

News Archive

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

New advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are proving far superior to standard radiation procedures used today in safeguarding the healthy tissues surrounding cancerous tumors, and thus improving patient care.

Beckman Coulter announces PMA from FDA for Prostate Health Index

Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies.

Roche to commence clinical study of TB-403 in patients with colorectal and ovarian cancer

BioInvent International AB and ThromboGenics NV announce today that their partner Roche will begin an imaging study with the novel anti-cancer antibody TB-403 (RG7334) in patients with metastatic, treatment-refractory, colorectal and ovarian cancer.

Cord Blood America announces retirement of $1.6 million in debt since July 2009

Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it has retired $1.6 million in debt since July 2009. The Company previously announced it retired $5 million in debt in the first half of 2009.

Scientists back the use of maize as an efficient 'factory' for protein-based pharmaceutical products

Scientists from the Universidad de Lleida (University of Lleida) have published a study confirming that maize seeds are an effective and sure platform within molecular agriculture to alleviate diseases. Over the next few years AIDS could be one of the first diseases to benefit from these results, although regulations for this technology are being developed at the same time as research is being undertaken.

Read more News

› Verified 7 days ago


Nursing Homes in Festus, MO

Crystal Oaks
Location: 1500 Calvary Church Road, Po Box 680, Festus, Missouri 63028
Phone: (636) 933-1818    
Festus Manor
Location: 627 Westwood Drive South, Festus, Missouri 63028
Phone: (636) 931-9066    
Fountainbleau Nursing Center
Location: 1349 Highway 61, Po Box 700, Festus, Missouri 63028
Phone: (636) 937-3500    

Nursing Home

A nursing home (also called skilled nursing facility) is a facility or distinct part of an institution whose primary function is to provide medical, continuous nursing, and other health and social services to patients who are not in an acute phase of illness requiring services in a hospital, but who require primary restorative or skilled nursing services on an inpatient basis above the level of intermediate or custodial care in order to reach a degree of body functioning to permit self care in essential daily living.

A skilled nursing facility (SNF) may be a freestanding facility or part of a hospital that has been certified by Medicare to admit patients requiring subacute care and rehabilitation.

Nursing Home Compare

Nursing Home Compare allows consumers to compare information about nursing homes. It contains quality of care and staffing information for all 15,000 plus Medicare- and Medicaid-participating nursing homes.

Note: Nursing homes aren't included on Nursing Home Compare if they aren't Medicare or Medicaid certified. These Nursing Homes can be licensed by the state.

Information on Nursing Home Compare isn't an endorsement or advertisement for any nursing home and should be considered carefully. Use it with other information you gather about nursing homes facilities. Talk to your doctor or other health care provider about the information on Nursing Home Compare.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.